Portrait of Amir Mahmoud, MBBCh

Amir Mahmoud, MBBCh

Assistant Professor

Address: 

  • Hematology Division
    Mail Stop MSC-8125-29-10700, Mid-Campus Center, 4590 Nash Way, 10th floor suite 10700, St. Louis, MO 63110

Research Interest: Thrombosis and hemostasis; thrombotic microangiopathies; antiphospholipid syndrome; cancer-associated thrombosis

Research: My research focuses on identifying modifiable factors that influence morbidity and mortality in patients with high-risk thrombotic conditions including microangiopathies, antiphospholipid syndrome, and cancer-associated thrombosis. Through clinical outcome research and clinical trials, the long-term objective of my work is to improve clinical outcomes and develop new therapies for patients with thrombotic conditions.

Biosketch

Education

  • Present–2026: Master of Science in Clinical Investigation (MSCI), Washington University School of Medicine in St. Louis, MO (in progress)
  • 2019–2017: Master of Medicine, Ain Shams University, Faculty of Medicine, Cairo, Egypt
  • 2015–2009: Medical Degree (MBBCh), Ain Shams University, Faculty of Medicine, Cairo, Egypt

Post-Graduate Training

  • 2026–2024: Hematology Fellowship (ASH HFFTP), Washington University School of Medicine in St. Louis, MO
  • 2024–2021: Internal Medicine Residency, Rochester General Hospital, Rochester, NY
  • 2020–2017: Hematology and Bone Marrow Transplant Residency, Ain Shams University Hospital, Faculty of Medicine, Cairo, Egypt

Academic Positions

  • 2026–present: Assistant Professor of Medicine, Division of Hematology, Washington University School of Medicine in St. Louis, MO

University & Hospital Appointments & Committees

  • 2014-present: Co-Head, Immunomonitoring Laboratory, Bursky Center for Human Immunology and Immunotherapy Programs (CHiiPs)

Board Certification

  • 2024: American Board of Internal Medicine (Internal Medicine)

Honors & Awards

  • 2026: ICTS PROUD-MED
  • 2026: Evan Sadler Award
  • 2025: ASH CRTI Award
  • 2025: ASH CHAMP Award

Panels & Committees

  • 2026–present: Member of the ISTH SSC subcommittee on APS

Professional Societies & Organizations

  • 2025–present: International Society on Thrombosis and Haemostasis (ISTH)
  • 2023–present: Hemostasis and Thrombosis Research Society (HTRS)
  • 2022–present: American Society of Hematology (ASH)

Selected Publications

  • Treatment delay and outcomes in elderly thrombotic thrombocytopenic purpura patients: A nationwide analysis
    Mahmoud AA, Abdelhay A, Mostafa M, Yassin H, Jadhav N, Kouides P. Am J Hematol. 2023 Jul;98(7):E161-E164. doi: 10.1002/ajh.26926. Epub 2023 Apr 13. PMID: 37052189.
  • Severe cutaneous necrosis in antiphospholipid syndrome
    Mostafa M, Mahmoud AA, Egiza HA, Niu C, Elbahnasawy M, Yusuf Y, Kouides P. Am J Hematol. 2023 Nov;98(11):E328-E333. doi: 10.1002/ajh.27067. Epub 2023 Sep 15. PMID: 37713504.
  • Association Between Anticoagulant-Related Bleeding and Mortality in Patients With Solid Tumors and Cancer-Associated Venous Thromboembolism
    Mahmoud AA, Luo S, Gage BF, Afzal A, Carson K, Chang SH, Schoen M, Wang TF, Sanfilippo KM. Am J Hematol. 2025 Mar;100(3):535-538. doi: 10.1002/ajh.27588. Epub 2025 Jan 21. PMID: 39835402; PMCID: PMC11909763.
  • Reduced-Dose Versus Full-Dose Direct Oral Anticoagulants for Extended Secondary Venous Thromboembolism Prophylaxis in Cancer Patients: A Systematic Review and Meta-Analysis of Randomized Trials
    Mahmoud AA, Eltaher B, Shah P, Vengilote R, Mostafa M, Afzal A, Sanfilippo KM. Am J Hematol. 2025 Dec;100(12):2276-2285. doi: 10.1002/ajh.70090. Epub 2025 Sep 24. PMID: 40990099.
  • Association of anticoagulant therapy with bleeding in patients with chronic liver disease: A case-cross over study using the National Veterans Health Administration database
    Mahmoud AA, Sanfilippo KM, Gage BF, Luo S, Afzal A. Thromb Res. 2025 Dec;256:109529. doi: 10.1016/j.thromres.2025.109529. Epub 2025 Nov 6. PMID: 41218267.